The District Court and In the News blogs will be out for finals and the subsequent holidays. We’ll see you again in January. Happy Holidays!
GlaxoSmithKline wins a preliminary injunction to stop the implementation of the PTO’s new claims and continuation rules.
Not all tech companies are in lock step with each other in the patent reform debate, as the Innovation Alliance has shown.
GlaxoSmithKline has reviewed the new USPTO rules. It their contention that the rules exceed the PTO’s authority and are unconstitutional.